Your Search Returned 500 tagged news reports
First, there was the rock-hard lymph node above my collarbone that disappeared with one night of steroids, even before I started chemotherapy. Then, there was the chest x-ray done only a few days after starting my first round of chemo. It's not
Yearly mammograms in middle-age women do not reduce breast cancer deaths these tests are essentially as good as physical examination alone, according to a new 25-year study from Canada. The study, which included nearly 90,000 women ages 40 to 59, is
Ali Stunt, chief executive of PCA, says that despite widespread criticism, the campaign achieved its aims Any type of cancer is a horrible disease but, thankfully, funding and campaigning has seen the survival rates for many types of the disease
A Missouri Senate panel has advanced legislation that could lower costs for some cancer patients. Bills endorsed Tuesday by the Senate insurance committee would require insurance companies to charge patients the same out-of-pocket costs for
National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/f_guidelines.asp...Use of pharmacologic intervention for breast cancer risk reduction: American Society of Clinical Oncology clinical practice guideline.
11 February 2014 0 View comments The glasses were used by Dr Julie Margenthaler during breast surgery in Missouri this week, pictured Surgeons could soon be able to identify and remove infected tissue from cancer patients simply by looking at it.
Bladder cancer, which is the fourth most common malignancy in men and ninth most common in women in the United States, claimed more than 15,000 patients last year. The analysis of 262 bladder cancer tumors, published online by the Proceedings of the
An Italian pharmaceutical company said Tuesday it has manufactured a cheap, effective drug that drastically reduces sometimes fatal chemotherapy side effects in blood-cancer patients. Florence-based Menarini Group, which is about to register the drug
Smartphone apps aimed at preventing cancer, or helping people with the disease to manage it, have the potential to improve people's health, but many of these apps have drawbacks, researchers say. In a new study, researchers reviewed 295 cancer-
Fluxion currently offers a broad range of analytical services using its IsoFlux System for circulating tumor cell (CTC) enrichment, including qPCR and next-generation sequencing (NGS) based assays...Fluxion's Discovery Services are available to